ArticlePharmacological reports : PR2021
Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β.
Hisham F Bahmad et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it